Guardant Health Q3 2026 Results: Net Loss of $124M, Loss Widens
Guardant Health reported revenue of $361.0 million for the third quarter of 2026, a 36% increase compared to the same period in 2025. Despite the revenue growth, the company experienced a net loss of $124.4 million for the quarter, driven by increased sales, marketing, and general administrative expenses.
- Key figure
- Net loss $124M